These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

571 related items for PubMed ID: 19703372

  • 1. Rapid absorption of sumatriptan powder and effects on glyceryl trinitrate model of headache following intranasal delivery using a novel bi-directional device.
    Luthringer R, Djupesland PG, Sheldrake CD, Flint A, Boeijinga P, Danjou P, Demazières A, Hewson G.
    J Pharm Pharmacol; 2009 Sep; 61(9):1219-28. PubMed ID: 19703372
    [Abstract] [Full Text] [Related]

  • 2. Intranasal sumatriptan powder delivered by a novel breath-actuated bi-directional device for the acute treatment of migraine: A randomised, placebo-controlled study.
    Djupesland PG, Docekal P, Czech Migraine Investigators Group.
    Cephalalgia; 2010 Aug; 30(8):933-42. PubMed ID: 20656704
    [Abstract] [Full Text] [Related]

  • 3. Zelrix: a novel transdermal formulation of sumatriptan.
    Pierce M, Marbury T, O'Neill C, Siegel S, Du W, Sebree T.
    Headache; 2009 Jun; 49(6):817-25. PubMed ID: 19438727
    [Abstract] [Full Text] [Related]

  • 4. A Randomized Trial Comparing the Pharmacokinetics, Safety, and Tolerability of DFN-02, an Intranasal Sumatriptan Spray Containing a Permeation Enhancer, With Intranasal and Subcutaneous Sumatriptan in Healthy Adults.
    Munjal S, Gautam A, Offman E, Brand-Schieber E, Allenby K, Fisher DM.
    Headache; 2016 Oct; 56(9):1455-1465. PubMed ID: 27613076
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks.
    Tepper SJ, Cady RK, Silberstein S, Messina J, Mahmoud RA, Djupesland PG, Shin P, Siffert J.
    Headache; 2015 May; 55(5):621-35. PubMed ID: 25941016
    [Abstract] [Full Text] [Related]

  • 7. Distinct pharmacokinetic profile and safety of a fixed-dose tablet of sumatriptan and naproxen sodium for the acute treatment of migraine.
    Haberer LJ, Walls CM, Lener SE, Taylor DR, McDonald SA.
    Headache; 2010 Mar; 50(3):357-73. PubMed ID: 20132340
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term tolerability of sumatriptan nasal spray in adolescent patients with migraine.
    Natarajan S, Jabbour JT, Webster CJ, Richardson MS.
    Headache; 2004 Mar; 44(10):969-77. PubMed ID: 15546259
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A novel intranasal breath-powered delivery system for sumatriptan: a review of technology and clinical application of the investigational product AVP-825 in the treatment of migraine.
    Cady R.
    Expert Opin Drug Deliv; 2015 Mar; 12(9):1565-77. PubMed ID: 26119828
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Injectable sumatriptan: now needle-based or needle-free.
    Rothrock JF.
    Headache; 2010 Feb; 50(2):343-4. PubMed ID: 20456140
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.